Pharmacogenomics of Mood Disorder in Chronic Kidney Disease Patients

Cohort Study on the Psychiatric Outcomes and Genetic Associations in Patients With Chronic Kidney Disease

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06675396

Acronym

CKD

Enrollment

300

Registered

2024-11-05

Start date

2024-12-01

Completion date

2028-12-31

Last updated

2024-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease(CKD), Depression

Keywords

CKD, Mood disorder

Brief summary

By using genetic information we could predict the prevalence of mood disorder and response to treatment.

Detailed description

This prospective cohort study enrols patients with chronic kidney disease and gathers genetic information. By the patient's biochemical information, including genetic information, we could predict the prevalence of mood disorder and response to the antipsychotherapy.

Interventions

OTHERAntidepressants

control

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 90 Years

Healthy volunteers

Inclusion criteria

* CKD patients aged 18 to 90 years

Exclusion criteria

* no CKD patients, aged below 18 or above 90 years

Design outcomes

Primary

Measure	Time frame	Description
Prevalence of depression	10 years	Prevalence of depression

Contacts

Primary ContactJun Young Lee Lee Jun Young Professor

junyoung07@yonsei.ac.kr800-555-5555

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026